NL8601434A - Chinolinederivaten. - Google Patents
Chinolinederivaten. Download PDFInfo
- Publication number
- NL8601434A NL8601434A NL8601434A NL8601434A NL8601434A NL 8601434 A NL8601434 A NL 8601434A NL 8601434 A NL8601434 A NL 8601434A NL 8601434 A NL8601434 A NL 8601434A NL 8601434 A NL8601434 A NL 8601434A
- Authority
- NL
- Netherlands
- Prior art keywords
- general formula
- formula
- acid addition
- sheet
- formula sheet
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU219385 | 1985-06-04 | ||
| HU852193A HU195487B (en) | 1985-06-04 | 1985-06-04 | Process for producing quinoline derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL8601434A true NL8601434A (nl) | 1987-01-02 |
Family
ID=10958222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL8601434A NL8601434A (nl) | 1985-06-04 | 1986-06-04 | Chinolinederivaten. |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US4652562A (fi) |
| JP (1) | JPS6248668A (fi) |
| KR (1) | KR930006775B1 (fi) |
| CN (1) | CN1012957B (fi) |
| AT (1) | AT392469B (fi) |
| AU (1) | AU588883B2 (fi) |
| BE (1) | BE904864A (fi) |
| CA (1) | CA1266650A (fi) |
| CH (1) | CH668069A5 (fi) |
| CS (1) | CS257793B2 (fi) |
| DD (1) | DD247448A5 (fi) |
| DE (1) | DE3618724C2 (fi) |
| DK (1) | DK162841C (fi) |
| ES (1) | ES8707231A1 (fi) |
| FI (1) | FI82451C (fi) |
| FR (1) | FR2582835B1 (fi) |
| GB (1) | GB2176185B (fi) |
| GR (1) | GR861452B (fi) |
| HU (1) | HU195487B (fi) |
| IL (1) | IL79024A0 (fi) |
| IT (1) | IT1204377B (fi) |
| NL (1) | NL8601434A (fi) |
| NO (1) | NO165635C (fi) |
| PH (1) | PH24135A (fi) |
| PL (1) | PL146498B1 (fi) |
| PT (1) | PT82712B (fi) |
| SE (1) | SE466308B (fi) |
| SU (1) | SU1398773A3 (fi) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6331286B1 (en) | 1998-12-21 | 2001-12-18 | Photogen, Inc. | Methods for high energy phototherapeutics |
| US8974363B2 (en) * | 1997-12-11 | 2015-03-10 | Provectus Pharmatech, Inc. | Topical medicaments and methods for photodynamic treatment of disease |
| US8557298B2 (en) * | 1998-08-06 | 2013-10-15 | Provectus Pharmatech, Inc. | Medicaments for chemotherapeutic treatment of disease |
| US20090117199A1 (en) * | 1998-08-06 | 2009-05-07 | Scott Timothy C | Method of treatment of cancer |
| US7384623B1 (en) | 1998-12-21 | 2008-06-10 | Provectus Pharmatech, Inc. | High energy phototherapeutic agents |
| US20020001567A1 (en) * | 1998-12-21 | 2002-01-03 | Photogen, Inc. | Intracorporeal medicaments for high energy phototherapeutic treatment of disease |
| US8470296B2 (en) * | 1998-12-21 | 2013-06-25 | Provectus Pharmatech, Inc. | Intracorporeal medicaments for high energy phototherapeutic treatment of disease |
| EP1719770A3 (en) * | 2000-09-21 | 2008-03-05 | Smithkline Beecham Plc | Quinoline derivatives as antibacterials |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU165520B (fi) * | 1972-05-05 | 1974-09-28 | ||
| IE47458B1 (en) * | 1977-11-07 | 1984-03-21 | Leo Pharm Prod Ltd | Quinolylguanidine derivatives |
-
1985
- 1985-06-04 HU HU852193A patent/HU195487B/hu not_active IP Right Cessation
-
1986
- 1986-05-28 CH CH2153/86A patent/CH668069A5/de not_active IP Right Cessation
- 1986-05-30 DD DD86290766A patent/DD247448A5/de not_active IP Right Cessation
- 1986-06-03 BE BE0/216734A patent/BE904864A/fr not_active IP Right Cessation
- 1986-06-03 CN CN86103688A patent/CN1012957B/zh not_active Expired
- 1986-06-03 AT AT1492/86A patent/AT392469B/de not_active IP Right Cessation
- 1986-06-03 PH PH33848A patent/PH24135A/en unknown
- 1986-06-03 KR KR1019860004409A patent/KR930006775B1/ko not_active IP Right Cessation
- 1986-06-04 SU SU864027590A patent/SU1398773A3/ru active
- 1986-06-04 IL IL79024A patent/IL79024A0/xx not_active IP Right Cessation
- 1986-06-04 PT PT82712A patent/PT82712B/pt unknown
- 1986-06-04 IT IT20667/86A patent/IT1204377B/it active
- 1986-06-04 JP JP61130006A patent/JPS6248668A/ja active Granted
- 1986-06-04 CS CS864112A patent/CS257793B2/cs unknown
- 1986-06-04 AU AU58344/86A patent/AU588883B2/en not_active Ceased
- 1986-06-04 SE SE8602524A patent/SE466308B/sv not_active IP Right Cessation
- 1986-06-04 CA CA000510779A patent/CA1266650A/en not_active Expired - Lifetime
- 1986-06-04 US US06/870,396 patent/US4652562A/en not_active Expired - Fee Related
- 1986-06-04 DE DE3618724A patent/DE3618724C2/de not_active Expired - Fee Related
- 1986-06-04 GR GR861452A patent/GR861452B/el unknown
- 1986-06-04 DK DK262186A patent/DK162841C/da not_active IP Right Cessation
- 1986-06-04 ES ES555708A patent/ES8707231A1/es not_active Expired
- 1986-06-04 GB GB08613530A patent/GB2176185B/en not_active Expired
- 1986-06-04 NO NO862230A patent/NO165635C/no unknown
- 1986-06-04 FI FI862381A patent/FI82451C/fi not_active IP Right Cessation
- 1986-06-04 PL PL1986259871A patent/PL146498B1/pl unknown
- 1986-06-04 NL NL8601434A patent/NL8601434A/nl not_active Application Discontinuation
- 1986-06-04 FR FR8608039A patent/FR2582835B1/fr not_active Expired
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7452996B2 (en) | Substituted quinoline derivatives | |
| CN109384782A (zh) | 取代五元并六元杂环类化合物、其制备方法、药物组合及其用途 | |
| AU570529B2 (en) | 5-heteroarylimidazol-2-ones | |
| CH707498B1 (de) | Heterocyclische Dihydro-Fünfring-Ketonderivate als DHODH-Inhibitor und ihre Verwendung. | |
| JPH0649697B2 (ja) | 放射線治療または化学療法に有用な化合物 | |
| NL8601434A (nl) | Chinolinederivaten. | |
| CN101307038A (zh) | 4-苄基哌连乙亚胺酰(亚胺甲基苯)肼类化合物、其制备方法、药物组合物和用途 | |
| JPS6140286A (ja) | 強心剤として有用な１，６−ナフチリジン−２（１ｈ）−オン | |
| SU873872A3 (ru) | Способ получени производных аминопропанола или их солей | |
| Glazer et al. | Pyridoquinoxaline N-oxides. 1. A new class of antitrichomonal agents | |
| US6037357A (en) | N-benzoyl-α-alkylated azatyrosines as anticancer agents | |
| EP3195867A1 (en) | Pyrimidine compounds inhibiting the formation of nitric oxide and prostaglandin e2, method of production thereof and use thereof | |
| JP2793312B2 (ja) | 放射線増感剤および選択的な細胞毒素剤としての１，２，４―ベンゾトリアジンオキシド | |
| JP2000212087A (ja) | ニトロ―５―デアザフラビン誘導体を有効成分とする放射線増感剤。 | |
| EP0316967B1 (en) | Fluorine-containing nitroimidazole derivatives and radiosensitizer comprising the same | |
| JP2000500747A (ja) | 血液調節化合物 | |
| JPS60246377A (ja) | 新規な複素環化合物を含有する組成物 | |
| Humphrey | Targeting histone H3K36me3-deficient cancers | |
| CA1301770C (en) | Isothiuronium salts | |
| CN118561729A (zh) | 一种硝基环状化合物的合成方法及其用途 | |
| IE54326B1 (en) | Decarboxylase-inhibiting fluorinated alkane diamine derivatives | |
| CN116332833A (zh) | 线粒体靶向光敏剂化合物及其制备方法和应用 | |
| KR20200102565A (ko) | 피라졸로피리다진 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 암 예방 또는 치료용 약학적 조성물 | |
| AU2017245930A1 (en) | Process for preparing oxathiazin-like compounds | |
| GB2104072A (en) | Fluorinated diaminoalkene derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BV | The patent application has lapsed |